chrisvoncsefalvay/vaers-outcomes huggingface dataset:
swollen lymph nodes on her one arm; This is a spontaneous report received from a contactable consumer (patient). A 74-years-old female patient (not pregnant at the time of vaccination) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: ER8729), dose 2 via an unspecified route of administration, in left arm on 07Apr2021 15:00 (at 74-years age) last Wednesday as single dose for covid-19 immunisation and patient received her first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EN6207) via an unspecified route of administration, in left arm on 17Mar2021 15:15 as single dose for covid-19 immunisation. The patient medical history was not reported. Patient was not allergic to medications, food, or other products. Concomitant medication(s) the patient received within 2 weeks of vaccination included gabapentin (GABAPENTIN); rosuvastatin (ROSUVASTATIN); diclofenac (DICLOFENAC); misoprostol (MISOPROSTOL). The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. On 08Apr2021 19:00 patient had experienced swollen lymph nodes on her one arm starting Thursday night up to today. No treatment received for reported adverse event. Patient not tested for COVID-19 after the vaccination. The outcome of the events was not resolved.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
12 hours after the shot I was sick with flu like symptoms and fever for about 30 hours.  Then I developed a localized red rash around the injections site that is about 5 '' by 4''
pt recv vax 3FEB99 & mom stated child c/o pain in lt arm;Wednesday PM put cold compress on arm;5FEB99 pt again complained & mom rubbed the area w/alcohol & sent alcohol pads to school w/child;5FEB99 T100, reddened area 3" x 2 3/4";
Stomach bloating. Some pain to touch. Attempted a bowel movement. Hard stool. Unusual as my liquid consumption has not been below my standard daily intake.
May 17th I had my first facial reaction.   Face swelled, weeped fluid, itched, skin peeled.     It has been happening off and on ever since.    I went to Dr on 6/22 and was put on prednisone for 5 day; May 17th I had my first facial reaction.   Face swelled, weeped fluid, itched, skin peeled.     It has been happening off and on ever since.    I went to Dr on 6/22 and was put on prednisone for 5 day; May 17th I had my first facial reaction.   Face swelled, weeped fluid, itched, skin peeled.     It has been happening off and on ever since.    I went to Dr on 6/22 and was put on prednisone for 5 day; May 17th I had my first facial reaction.   Face swelled, weeped fluid, itched, skin peeled.     It has been happening off and on ever since.    I went to Dr on 6/22 and was put on prednisone for 5 day; my eyes were puffing up; My cycles have stopped; My cycles have stopped; This is a spontaneous report from a contactable consumer or other non-hcp (Patient). A 52-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection; Lot Number: EW0169) via an unspecified route of administration (age at vaccination 52-year) in right arm on 02May2021 at 12:30 PM as dose 2, single for COVID-19 immunization. Medical history reported none. There were no concomitant medications. Historical vaccine includes first dose of BNT162B2 (Lot number: EP7533) administered in right arm on 11Apr2021 at 12:30 PM for COVID-19 immunization. No known allergies were reported. The patient received no COVID prior vaccination. The patient not tested COVID post vaccination. Patient received no other vaccine in four weeks. Other medications in two weeks were reported none. On 17May2021 at 05:00 PM the patient experienced she had her first facial reaction, Face swelled, weeped fluid, itched, skin peeled, it had been happened off and on ever since, she went to Dr on 6/22 and was put on prednisone for 5 day, her eyes were puffing up, her cycles have stopped. AE resulted in Doctor or other healthcare professional office/clinic visit. The patient reported that "17May she had her first facial reaction. Face swelled, weeped fluid, itched, skin peeled. It has been happening off and on ever since. She went to Dr on 22Jun and was put on prednisone for 5 days and symptoms improved. Took last medication on a Sunday morning and by Monday evening her eyes were puffing up. They put her on a 10-day lower dosage of prednisone. Did not have the same effect as the first round but kept things in check. she experienced another reaction. They tried to rule out any type of allergy to food or contact. She had no history of any type of allergic reaction to food, plants, or seasonal allergies. She also had regular menstrual cycles with no signs of menopause. Her cycles had stopped." Therapeutic measures were taken as a result of adverse events; the patient was treated with prednisone, started on 22Jun. The clinical outcome of the events was not resolved.  Follow-up attempts are completed. No further information is expected.
Fever fatigue, chills Narrative:  Per supervisor report: "received COVID Vaccine on Monday [sic: Wed. 8/11] and is requesting [leave] for symptoms of fever, fatigue, chills."
Pt recvd vax & devel hives; pt was treated w/Antihistamines (DPH); reporting MD indicated pt devel hives on 2 separate occasions unrelated to vax; A thimerosal allergy may exist;
All over body rash with some shortness of breath without acute distress.  Seen in Emergency Room received Benadryl and DepoMedrol.  Given DepoMedrol dose pack with discharge.  Symptoms cleared significantly 1/4/06.
all of a sudden she has energy and reports, "it feels like they shot me up with steroids or something."; This is a spontaneous report from a contactable consumer (patient). A female patient of age 81 (units not provided) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The caller stated she received the second dose of the Covid vaccine on Sunday (unspecified date) and reported not experiencing any side effects, absolutely no reactions whatsoever. She touched the area where the injection was given and nothing, no pain, no hurt. Caller stated all of a sudden, she had energy and reported: it feels like they shot me up with steroids or something. Caller also asked if Pfizer Covid vaccine was stored in the freezer. She stated, when it was out of the freezer, as she assumed it has a life of it was own and it was perfectly fine to give. Caller reported not seeing any freezers at her vaccination center in the mall. The outcome of event was unknown.   Follow-up attempts are completed. No further information is expected.
Rotavirus administered on 4/13/07 seen in ER for vomiting, diarrhea T 103.5 > 4/14/07 Admitted Diarrhea and Dehydration 4/16/07 weight decreased 17oz. follow up visit, weight up 5 1/2 oz. 4/19/07 PLAN: follow weight 1 week.  4/27/07 Received medical records from hospital which reveal patient experienced vomiting, fever & diarrhea for 2 days.  Seen in ER & d/c to home.  Vomiting & diarrhea persisted & was admitted on 4/16/07.   Exam revealed reddened TMs.  Admitted for IVF & monitoring.  No D/C summary or consults available at this time. FINAL DX: none provided.  Will request medical records when complete. 6/1/07 Received hospital D/C summary which reveals pt d/c to home 4/17/07. FINAL DX: acute gastroenteritis, resolved; UTI, ruled out.
Immediate reaction feeling sore, achy and fatigue. Felt very ill for three days. Had rash on vaccination arm. Most troubling was the oral herpes infection that appeared on day three. Multiple sores that took weeks to heal. Scarring.
Severe vertigo; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Severe vertigo) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced VERTIGO (Severe vertigo). At the time of the report, VERTIGO (Severe vertigo) had not resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.  Concomitant medications were not reported.  Treatment for the event was not specified.; Sender's Comments: Very limited information regarding this event has been provided at this time.  Further information has been requested.
Every one she knows had flu-like symptoms; This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in an unspecified number of patients who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced influenza-like symptoms. On an unknown date, the outcome of the influenza-like symptoms was unknown.   It was unknown if the reporter considered the influenza-like symptoms to be related to Shingrix.     Additional Information: GSK Receipt Date: 2-May-2022 Reporter's comments: The reporter stated that everyone she knows had a reaction to the Shingrix vaccine. She stated that the reaction were flu-like symptoms. Additional Supportive Information: This case was linked with case US2022072606, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022072606:Same reporter.
Vaccine breakthrough, asymptomatic, but turned symptomatic.   Inpatient admit 9/6-9/8.
1/24/02 Right lateral arm: 8.5 x 10 cm edematous / erythematous area of induration. After consult w/allergist - given Tylenol 325 + Zyrtec 10 mg.
190 patients (9 different lot numbers) received a vaccine past the beyond use by date; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond use by date) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond use by date) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond use by date) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond use by date).    This case was created for 127th patient of the 190 patients involved. Concomitant medication was not provided. It was unknown if patient received any other vaccines in the 4 weeks prior to COVID-19 Vaccine. Treatment information was not reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-704335 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-704335:CASE
4:30pm found alert but shaking in bed at a group living setting and then vomited.  Evaluated by medical staff there and sent by ambulance to local ER.  Returned to living setting at 6:50pm and resumed normal activities without any further symptoms or restrictions.
PA at clinic called my office on 10/15/02 stating mother had pt in the office this am and child has thrush. Mother asked to report it to me because pt had just had shots. Stated child had not been on any antibiotics. I had administered IPV, HIB and Varivax on 10/9/02. Note on acknowledgement letter states:  I spoke with mother 12/27/2002 and she said clinic told her the thrush was an side affect of the vaccines. Child wouldn't eat and mother looked in mouth and saw sores.
24 hours after shot-massive burning pain shooting through my left bicep, shoulder neck, and down my arm. On 5/22 the pain traveled to my right arm causing restrictions in movement. Went to PCP on 5/24 and was prescribed Prednisone for 5 days. The symptoms in my right arm were corrected and in my left arm increased in the burning pain. It is amplified or the weekend where it feels like there is a 1000lb weight hanging from my hand weighing down my arm, burning and shooting pain, and sometime makes my hand and fingers tingle and go numb. Went to Urgent Care on 5/30was prescribed Naproxen 550mg for 5days, with no change. They gave me a referral to get an MRI on shoulder and arm.
This 19 year old received third TWINRIX (SKB AHABB162BA) and first yellow fever (1F582AA and TYPHOID vaccinations afternoon of 24 Feb 2010.  Approximately 1 hour later after returning to his vehicle with group, he began to experience bilateral water itchy eyes and diffuse scalp itching.  He immediately returned to medical where his symptoms quickly progressed to tightness in his throat, shortness of breath, facial flushing sinus/ ear congestion, coughing, and pruritic hives to face/upper torso and extremities (witness by provider).  He was treated with 50 mg oral BENADRYL and SQ epinephrine (EPIPEN) with resolution of most symptoms within 5 minutes.  Hives and itching resolved after 25 minutes.  He was observed 1 hour and released to roommate.  SM reported no reoccurrence of symptoms 24 & 48 hours later and is using CLARITIN 10 mg daily X 5 then prn.  Activities 2/24/2010 included routine morning exercises then ate a chicken bacon sandwich from a deli with a cherry soda about 1 hour before vaccinations.  He denied any new deodorants, clothing, soaps, shampoos, (or exposure to), or food intake.  He took no vitamins or herbal supplements.
Noticing that I have a very low high pitch sound in my right ear with some fuzziiness that I sincerely believe started around the time of the second dose.
Patient sat and waited she was feeling like she could not swallow - she was given 10 mgs of  benadryl and was closely monitored. there were no breathing issues. After waiting, patient was feeling better and left with no issues.
pt recvd 2 doses of Engerix-B p/2nd dose had nausea, diarrhea, low grade fever, joint pain, rt upper quad pain;
Swollen eyes with rash; Swollen eyes with rash; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613), via an unspecified route of administration in left arm on 19Mar2021 at 10:45 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Medical history included allergy to amoxicillin-m. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications taken within two weeks of vaccination included CLARITIN-D and spironolactone (MANUFACTURER UNKNOWN) both for unknown indication and from an unknown date. The patient experienced swollen eyes with rash on 20Mar2021 at 15:00. No Therapeutic measures were taken for the reported adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events swollen eyes and rash was not recovered. No follow-up attempts are needed. No further information is expected.
This case was reported by a nurse via call center representative and described the occurrence of fever in a female patient who received ENGERIX B for prophylaxis. Previously administered products included Flu vaccine with an associated reaction of adverse reaction (received on an unknown date, refer case US2019GSK037462). On an unknown date, the patient received ENGERIX B at an unknown dose. On an unknown date, unknown after receiving ENGERIX B, the patient experienced fever. On an unknown date, the outcome of the fever was recovered/resolved. It was unknown if the reporter considered the fever to be related to ENGERIX B. Additional details were reported as follows: The age at vaccination was not reported. The nurse reported the patient received a past ENGERIX B vaccine, details unknown, and experienced a high fever for over one year. She stated there was a September 2011 date in the patient's profile related to the ENGERIX B, but she did not know if that was the date the patient received the vaccine, or if that was the date the patient reported the reaction. The nurse stated, at the time of initial report, she was unable to find other details related to patient's ENGERIX B vaccine details, including where she received vaccine, injection site location, lot number, expiration date, and doctor details.
I don't know the lot #.  I have the receipt for the 2nd Shingrex injection I got on 7/8/2011.  The next day, July 9, 2022, at 9pm at night I got 3 shooting pains in one of my lower right molars in my mouth.  On July 13, 2022 at 1pm I got shooting pain in three of my molars on right top side.  I've been having soreness in various nerves of the majority of my teeth since then.  I saw my dentist for a routine check up, cleaning and X-rays and I asked her about it and she stated it maybe due to the Shingrex shot.
knocked out very well for 3 days,; felt lack of energy; aches; This spontaneous case was reported by a consumer and describes the occurrence of LOSS OF CONSCIOUSNESS (knocked out very well for 3 days,) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001A21A and 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history was reported.).   On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LOSS OF CONSCIOUSNESS (knocked out very well for 3 days,) (seriousness criterion medically significant), ASTHENIA (felt lack of energy) and PAIN (aches). At the time of the report, LOSS OF CONSCIOUSNESS (knocked out very well for 3 days,), ASTHENIA (felt lack of energy) and PAIN (aches) had resolved. Not Provided    Treatment information was not provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested.
Intussusception 4/4/08-records received for DOS 12/28/17-1/15/08-DC DX: Intussusception. Suspected post intussusception peritonitis. Presented day prior to admission with 16 hours non-bilious non-bloody vomiting. Decreased appetite and urine output. No diarrhea. Day of admission developed current jelly/bloody stool. Barium enema showed irreducible intussusception and 2 unsuccessful attempts made. Laparotomy revealed no evidence of intussusception. Post operatively developed increasing abdominal distension and tenderness. Coagulopathy improved with FFP and blood transfusion. Recurrent vomiting and loose stools. Fever. Follow-up: Rotavirus vaccine given after incident without adverse events.
Head ache and fever of 101 degrees Called pharmacy and instructed to give Motrin and Tylenol
Patient is fully vaccinated and boosted.  COVID + on admission to hospital 2/12/2022. Patient presents with shortness of breath, cough. No respiratory distress. SpO2 95% on room air.The patient has been having several days to over 1 week of generalized fatigue and malaise. CXR: No definite focal infiltrate is seen. Treatments:  DVT prophylaxis with heparin SQ. Decadron.  Pt on 3L NC. Discharged home.
Breakthrough case admission after 3 vaccines Moderna 2/9/21 Lot# 007M20A;  Moderna 3/9/21t# 030A21A;  Moderna 10/9/21 Lot# 011f21A
Pt recd vaxs; immed thereafter pt had what appeared to be a focal sz & was unresponsive for 10-15 sec; had full recovery;
4/5/21 triage: Pt was in ED with son who was a pt today. Pt walked outside where she became light headed & briefly loss consciousness. This nurse witnessed pt knees begin to buckle & son lowered her to ground. Pt states "sometimes I get light headed if I haven't had enough water". Pt alert/oriented @ this time. C/o upper back pain that she states is new for her.  orthostatic positive HPI: 67 y.o. female who presents with a near syncopal episode just PTA. She feels that she is dehydrated. No chest pain. Some cough, no dyspnea or fever. No hx of CAD.  elevated troponin 1.28; 2.27 transferred to other HCF  hpi: History of Present Illness:   The patient is a 67 y.o. female with a past medical history notable for diabetes mellitus, hypertension, glaucoma who presents with chief complaint of "short of breath." Patient lives at home.Patient code status is:  Full code status.    Patient reports she has been battling a head cold over the past 2 weeks.  Patient has had low-grade fever of 99° F. Otherwise, patient has done well.  Patient had brought her son to the hospital emergency department.  When patient was getting ready to leave his room in the emergency department she says she felt sudden shortness of breath and dizziness.  Patient reported that she said ?I do not think I can make it.?  Patient then proceeded to get weak and syncopized.  Patient's son was already at her side and laid her on the ground.  Patient never hit her head.  When patient had return of consciousness, she continued to feel short of breath and dizzy.  Patient reported that sometimes she feels a sensation at home when she is dehydrated and has not drink in enough fluids.  Patient denies having any chest pain, fever, nausea, or vomiting.   Patient presented to the ED with the following vital signs:  Temperature 97.5°, heart rate 88, blood pressure 183/99, respiratory rate 24, oxygen saturation 85% on room air.  EKG was read as normal.  Laboratory findings reported as troponin I 0.11, repeat troponin I 3 hours later revealed 1.28.  Other laboratory findings significant for glucose 127, BUN 30, creatinine 1.2.  Chest x-ray was read as unremarkable. Patient given the following medications in the emergency department:  IV fluids x2 L bolus, 324 p.o. Aspirin, nitroglycerin ointment, treatment dose Lovenox.     During my evaluation of patient, patient denied having any chest pain.  Patient reported that she was feeling okay.   Patient was admitted to Internal Medicine service for further management of NSTEMI.
This spontaneous report as received from a 59 years old male patient with no drug reactions concerning himself. The patient's medical history included shingles happened in September 2012 to December 2012. The patient was vaccinated with a dose of ZOSTAVAX (1 time vaccine, subcutaneously, lot # was unknown) on 28-DEC-2012. There were no concomitant medications. On 28-DEC-2012 after 2 hours vaccination, the patient had a hard red lump at the injection site on his right arm. He also stated he had muscle pain. The patient did not seek medical attention. No treatment was given to the adverse events. No lab diagnostics were performed. The outcome of the adverse events was unknown at the time of report. The relatedness between adverse events and ZOSTAVAX was unknown. Additional information is not expected.